TrialNutrients2020

Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study.

María Benlloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.